Track topics on Twitter Track topics that are important to you
What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...
Follicle-stimulating hormone (FSH) now has become an established means of ovulation induction (OI) as part of assisted reproductive technology (ART). FSH is used to induce development of multiple foll...
US biotech OPKO Health has said it will continue with clinical development of its long-acting human growth hormone product (hGH-CTP), even though it has failed in a late stage trial in adult growth ho...
Searching for ways to look and feel young? Be wary of claims touting human growth hormone as an anti-aging regimen.
SEONGNAM, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), an innovative biotechnology company focused on immuno-oncology, metabolic and orphan diseases, announced today that US FDA ...
A new study examines how the sex hormone estrogen affects gene regulation in the brain, affecting the formation of fear memories and PTSD.
OPKO Health’s weekly growth hormone injection could be approvable in adults without need for further clinical trials, the company has told pharmaphorum. The biotech has worked with Pfizer to co-dev...
OPKO Health said today that the long-acting human growth hormone candidate hGH-CTP, which is being developed in adults with growth hormone deficiency under a collaboration with Pfizer, has failed a Ph...
Growth hormone replacement therapy may help improve physical function and quality of life among GH-deficient adults. Clinical Endocrinology
Genexine Inc. (KOSDAQ:095700) said FDA granted Orphan Drug designation to the company's GX-H9 to treat growth hormone deficiency (GHD).The company expects full data this year from a Phase II trial of ...
To extend available dosing options in the treatment of growth hormone deficiency, a comparative pharmacokinetic and pharmacodynamic phase-1 clinical study involving subcutaneous administration of grow...
Daily subcutaneous injection of human growth hormone has been used for the treatment of growth hormone deficiency and growth failure but has led to poor patient compliance and renal toxicity. Thus, it...
Although recombinant human growth hormone (rhGH) is not approved to treat short stature of achondroplasia (ACH), some studies suggested growth improvement during short-term rhGH treatment.
TV-1106 is a recombinant human albumin genetically fused to growth hormone which is intended to reduce the frequency of injections for GH therapy users. We report the safety, tolerability, pharmacokin...
This study is a first time assessment of safety and tolerability, pharmacokinetics, and pharmacodynamics of RO5046013 in human, in comparison with unmodified rhIGF-I.